Skip to content

Effects of Luo Han Guo on throat complications associated with tracheal intubation

Effects of Luo Han Guo on throat complications associated with tracheal intubation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012203
Enrollment
Unknown
Registered
2017-07-31
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Throat complications

Interventions

Experimental group:Postoperative treatment same as control group patients, oral Luo Han Guo decoction (0.5 g/kg
20 ml bolus every 2 h for 48 h)

Sponsors

Guigang City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) an oral tracheal intubation for anesthesia delivery within 10 min to complete an one-time operation; 2) an intraoperative tracheal intubation throat structure with a Cormack-Lehane grade of I~II [7]; 3) a sign informed consent for voluntary participation from a family member; 4) a general anesthesia intubation duration of 4 h; 5) a postoperative anesthesia recovery period; 6) a Steward Revival score of 6 points or more; 7) recovery of a swallowing reflex; 8) tracheal tube removal; 9) preoperative use of expectorant drugs (both oral and inhalation); and 10) postoperative anti-inflammatory treatment using a cefuroxime sodium injection.

Exclusion criteria

Exclusion criteria: 1) With throat disorder; 2) cardiovascular and cerebrovascular complications, respiratory insufficiency, liver, kidney, or immune system complications, severe infection, severe anemia, or other serious complications; 3) mental illness; 4) drug use for allergy or intolerance; 5) a midway intubation complicated by a respiratory tract infection; 6) an incomplete intubation; 7) intubation difficulty due to soft throat tissue abnormalities; 8) multiple intubations for a single patients; 9) a history of steroid use; 10) postoperative indwelling gastric tube; and 11) cognitive dysfunction with a history of asthma.

Design outcomes

Primary

MeasureTime frame
adverse reactions include hematuria, liver, kidney function, electrocardiogram, dizziness, itching, chest tightness, shortness of breath, nausea, vomiting;Sore throat, hoarseness, cough and sputum score incidence;

Countries

China

Contacts

Public ContactHuilian Tan

Guigang City People's Hospital

th693226@163.com+86 18978509176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026